Urinary tract infections (UTIs) are common bacterial infections affecting any part of the urinary system, including the kidneys, bladder, ureters, and urethra. Escherichia coli is a predominant causative agent, but other bacteria, viruses, or fungi can also lead to UTIs. Symptoms of UTIs may include frequent and painful urination, a strong urge to urinate, cloudy or foul-smelling urine, and pelvic pain. UTIs are more prevalent in women due to the shorter urethra, making it easier for bacteria to reach the bladder. Factors like sexual activity, urinary tract abnormalities, and a weakened immune system can increase the risk of UTIs. Diagnosis involves urine analysis, and treatment typically includes antibiotics to eliminate the infecting bacteria. Preventive measures include staying hydrated, practicing good hygiene, avoiding irritants like harsh soaps, and emptying the bladder regularly. Ongoing research focuses on understanding bacterial resistance, optimizing treatment regimens, and developing alternative preventive strategies for UTIs.
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Nanoscopic SubATVax™ adjuvanted vaccines against influenza A types H3N2, H1N1 and influenza type B for subcutaneous administration
David Craig Wright, D4 Labs, LLC, United States
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : Commensal bacteria drive B-cell lymphomagenesis in the setting of innate immunodeficiency
Ping Xie, Rutgers University, United States
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States